Exact Sciences Management Discusses Q2 2012 Results - Earnings Call Transcript

Exact Sciences (EXAS)

Q2 2012 Earnings Call

July 25, 2012 10:00 am ET

Executives

Rod Hise

Maneesh K. Arora - Chief Financial Officer, Chief Operating Officer, Principal Accounting Officer, Senior Vice President and Secretary

Kevin T. Conroy - Chief Executive Officer, President and Director

Analysts

Matthew M. Notarianni - Robert W. Baird & Co. Incorporated, Research Division

Brian Weinstein - William Blair & Company L.L.C., Research Division

Stephen S. Unger - Lazard Capital Markets LLC, Research Division

Charles C. Duncan - JMP Securities LLC, Research Division

Varun Dua - Jefferies & Company, Inc., Research Division

Jeffrey Frelick - Canaccord Genuity, Research Division

Zarak Khurshid - Wedbush Securities Inc., Research Division

John M. Putnam - Capstone Investments, Research Division

Bryan Brokmeier - Maxim Group LLC, Research Division

Raymond A. Myers - The Benchmark Company, LLC, Research Division

Presentation

Operator

Good day, ladies and gentlemen, and welcome to the Exact Sciences Corporation Second Quarter 2012 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Rod Hise. Please go ahead.

Rod Hise

Thank you, and thank all of you for joining us for Exact Sciences' second quarter 2012 conference call. On the call today are Kevin Conroy, the company's President and Chief Executive Officer; and Maneesh Arora, our Chief Operating and Financial Officer.

Exact Sciences issued a news release earlier this morning, detailing our second quarter 2012 financial results. If you've not seen the release, please go to our website at exactsciences.com or call (608) 807-4607, and I'll provide it to you.

If you liked this article you might like

Exact Sciences' Estimates Raised on Increased Contracts With Healthcare Providers

Exact Sciences Stock Falls on Secondary Stock Sale

Exact Sciences: Cramer's Top Takeaways

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)